Shahid Ahmed and his newly formed company, Nexus Pharmaceuticals, developed injectable drugs based on the confidential information Ahmed gleaned from a competitor, Bioniche Pharma claims in Lake County Court.

Two patent infringement complaints filed in Newark Federal Court seek to block Lupin Pharmaceuticals and Lupin Limited from obtaining FDA approval to sell a generic version of Tricor before the original patent expires.

%d bloggers like this: